Foghorn Therapeutics Files 2024 10-K
Ticker: FHTX · Form: 10-K · Filed: Mar 6, 2025 · CIK: 1822462
| Field | Detail |
|---|---|
| Company | Foghorn Therapeutics Inc. (FHTX) |
| Form Type | 10-K |
| Filed Date | Mar 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
Related Tickers: FHTX
TL;DR
Foghorn Tx (FHTX) filed its 2024 10-K. All systems go for 2025.
AI Summary
Foghorn Therapeutics Inc. filed its 2024 10-K on March 6, 2025, detailing its operations for the fiscal year ending December 31, 2024. The company, headquartered in Cambridge, MA, is focused on pharmaceutical preparations. The filing provides financial data and operational updates for the period, including comparative figures from 2023 and 2022.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Foghorn Therapeutics' financial health and business activities for the past fiscal year, crucial for understanding the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Foghorn Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period covered by the 10-K)
- 2023-12-31 — Prior Year End (Comparative financial data)
- 2022-12-31 — Previous Year End (Comparative financial data)
Key Players & Entities
- Foghorn Therapeutics Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-06 (date) — Filing date
- Cambridge, MA (location) — Company headquarters
- 0001822462 (company_id) — Central Index Key
FAQ
What is Foghorn Therapeutics' primary business activity?
Foghorn Therapeutics Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code [2834].
When did Foghorn Therapeutics file its 10-K for the fiscal year 2024?
Foghorn Therapeutics filed its 10-K for the fiscal year ending December 31, 2024, on March 6, 2025.
Where is Foghorn Therapeutics located?
Foghorn Therapeutics Inc. is located at 500 Technology Square, Suite 700, Cambridge, MA 02139.
What is the SEC file number for Foghorn Therapeutics?
The SEC file number for Foghorn Therapeutics Inc. is 001-39634.
What are the key financial reporting periods covered in this filing?
This 10-K filing covers the fiscal year ending December 31, 2024, and includes comparative financial data for the years ending December 31, 2023, and December 31, 2022.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 6, 2025 regarding Foghorn Therapeutics Inc. (FHTX).